← Open Payments lookup

KATIA MORENO: Open Payments

NPI 1538621693 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$750 in 39 payments from 13 companies in 2025. Trend: 2023 $709 · 2024 $473 · 2025 $750

Food & beverage: $750
CompanyPaymentsAmount
Celgene Corporation11$155
Novartis Pharmaceuticals Corporation5$98
ABBVIE INC.3$74
Genentech USA, Inc.3$71
E.R. Squibb & Sons, L.L.C.3$64
Gilead Sciences, Inc.3$61
Astellas Pharma US Inc2$43
Daiichi Sankyo Inc.2$40
GlaxoSmithKline, LLC.2$37
PUMA BIOTECHNOLOGY, INC.2$35

Products named: REBLOZYL, OPDUALAG, Trodelvy, VENCLEXTA, Fabhalta, Enhertu, Tecentriq, SCEMBLIX.

Industry payments across TX — which companies pay providers there.